491 related articles for article (PubMed ID: 26087073)
1. Approaches of targeting Rho GTPases in cancer drug discovery.
Lin Y; Zheng Y
Expert Opin Drug Discov; 2015; 10(9):991-1010. PubMed ID: 26087073
[TBL] [Abstract][Full Text] [Related]
2. Targeting Rho GTPase signaling for cancer therapy.
Mardilovich K; Olson MF; Baugh M
Future Oncol; 2012 Feb; 8(2):165-77. PubMed ID: 22335581
[TBL] [Abstract][Full Text] [Related]
3. Signaling through Rho GTPase pathway as viable drug target.
Lu Q; Longo FM; Zhou H; Massa SM; Chen YH
Curr Med Chem; 2009; 16(11):1355-65. PubMed ID: 19355891
[TBL] [Abstract][Full Text] [Related]
4. Rho GTPases: promising cellular targets for novel anticancer drugs.
Fritz G; Kaina B
Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways: targeting the kinase effectors of RHO-family GTPases.
Prudnikova TY; Rawat SJ; Chernoff J
Clin Cancer Res; 2015 Jan; 21(1):24-9. PubMed ID: 25336694
[TBL] [Abstract][Full Text] [Related]
6. Targeting Cancer by Using Nanoparticles to Modulate RHO GTPase Signaling.
Matos P; Pereira JFS; Jordan P
Adv Exp Med Biol; 2022; 1357():115-127. PubMed ID: 35583642
[TBL] [Abstract][Full Text] [Related]
7. Rho GTPases as therapeutic targets in cancer (Review).
Cardama GA; Gonzalez N; Maggio J; Menna PL; Gomez DE
Int J Oncol; 2017 Oct; 51(4):1025-1034. PubMed ID: 28848995
[TBL] [Abstract][Full Text] [Related]
8. Rho GTPases: Anti- or pro-neoplastic targets?
Zandvakili I; Lin Y; Morris JC; Zheng Y
Oncogene; 2017 Jun; 36(23):3213-3222. PubMed ID: 27991930
[TBL] [Abstract][Full Text] [Related]
9. Advances in the development of Rho GTPase inhibitors.
Zhang Y; Li G; Zhao Y
Bioorg Med Chem; 2023 Jul; 90():117337. PubMed ID: 37253305
[TBL] [Abstract][Full Text] [Related]
10. Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases.
Shang X; Marchioni F; Sipes N; Evelyn CR; Jerabek-Willemsen M; Duhr S; Seibel W; Wortman M; Zheng Y
Chem Biol; 2012 Jun; 19(6):699-710. PubMed ID: 22726684
[TBL] [Abstract][Full Text] [Related]
11. Targeting Cdc42 in cancer.
Arias-Romero LE; Chernoff J
Expert Opin Ther Targets; 2013 Nov; 17(11):1263-73. PubMed ID: 23957315
[TBL] [Abstract][Full Text] [Related]
12. Role of Rho GTPases in breast cancer.
Tang Y; Olufemi L; Wang MT; Nie D
Front Biosci; 2008 Jan; 13():759-76. PubMed ID: 17981586
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of Rho GTPases in cancer.
Porter AP; Papaioannou A; Malliri A
Small GTPases; 2016 Jul; 7(3):123-38. PubMed ID: 27104658
[TBL] [Abstract][Full Text] [Related]
14. Structure-function based design of small molecule inhibitors targeting Rho family GTPases.
Nassar N; Cancelas J; Zheng J; Williams DA; Zheng Y
Curr Top Med Chem; 2006; 6(11):1109-16. PubMed ID: 16842149
[TBL] [Abstract][Full Text] [Related]
15. Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers.
Aguilar BJ; Zhou H; Lu Q
Curr Med Chem; 2017; 24(32):3485-3507. PubMed ID: 28571533
[TBL] [Abstract][Full Text] [Related]
16. Role of Rho GTPases and their regulators in cancer progression.
Rathinam R; Berrier A; Alahari SK
Front Biosci (Landmark Ed); 2011 Jun; 16(7):2561-71. PubMed ID: 21622195
[TBL] [Abstract][Full Text] [Related]
17. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
[TBL] [Abstract][Full Text] [Related]
18. Rho GTPases: Promising candidates for overcoming chemotherapeutic resistance.
Zheng CW; Zeng RJ; Xu LY; Li EM
Cancer Lett; 2020 Apr; 475():65-78. PubMed ID: 31981606
[TBL] [Abstract][Full Text] [Related]
19. Rho GTPases as therapeutic targets in Alzheimer's disease.
Aguilar BJ; Zhu Y; Lu Q
Alzheimers Res Ther; 2017 Dec; 9(1):97. PubMed ID: 29246246
[TBL] [Abstract][Full Text] [Related]
20. Structural Mechanisms and Drug Discovery Prospects of Rho GTPases.
Smithers CC; Overduin M
Cells; 2016 Jun; 5(2):. PubMed ID: 27304967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
